Le Lézard
Classified in: Business
Subject: v

Dividend 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share


TORONTO, July 18, 2023 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. declares its monthly distribution of $0.10000 for each Class A share ($1.20 annualized) and $0.04583 for each Preferred share ($0.550 annually). Distributions are payable August 10, 2023 to shareholders on record as at July 31, 2023.

Since inception Class A shareholders have received a total of $26.30 per share and Preferred shareholders have received a total of $10.26 per share inclusive of this distribution, for a combined total of $36.56.

Dividend 15 invests in a high quality portfolio of leading Canadian dividend-yielding stocks as follows: Bank of Montreal, Bank of Nova Scotia, Canadian Imperial Bank of Commerce, Royal Bank of Canada, Toronto-Dominion Bank, National Bank of Canada, CI Financial Corp., BCE Inc., Manulife Financial, Enbridge, Sun Life Financial, TELUS Corporation, Thomson Reuters Corporation, TransAlta Corporation, TC Energy Corporation.

Distribution Details 
  
Class A Share (DFN)$0.10000
Preferred Share (DFN.PR.A)$0.04583
Record Date:July 31, 2023
Payable Date:August 10, 2023


Investor Relations: 1-877-478-2372Local: 416-304-4443www.dividend15.com[email protected]



These press releases may also interest you

at 07:45
Oracle Hospitality today announced that it has signed an agreement with Choice Hotels International, one of the largest lodging franchisors in the world, to extend its AI-powered merchandising solution Oracle...

at 07:45
The following issues have been halted by CIRO Company: Fraser Mackenzie Accelerator Corp. TSX-Venture Symbol: FMAC.P All Issues: Yes Reason: Pending News Halt Time (ET): 7:37 AM CIRO can make a decision to impose a temporary suspension (halt) of...

at 07:43
The Winners Circle, an innovative rewards programme and loyalty platform for horse racing fans, is delighted to announce its partnership with Saffie Osborne, an esteemed British flat racing jockey with more than 200 race wins....

at 07:40
Avicanna Inc. ("Avicanna" or the "Company) a biopharmaceutical company focused on the development, manufacturing, and commercialization of...

at 07:35
Smith Douglas Homes Corp. ("Smith Douglas" or the "Company") today announced first quarter results for the three months ended March 31, 2024. Q1 2024 Results as compared to Q1 2023: Net new orders increased 15% to 765 Home closings increased...

at 07:35
Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate...



News published on and distributed by: